Score Overview
Explore the 2021 public Archive ranking →
Where Utah Medical Products Inc has ranked, year by year
Showing 1 year ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- UTMD
2004: 60.1% · 2021: 74.4% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-29 | $ 74.95 | — |
1 Year2025-09-29 | $ 61.54 | 21.80% |
5 Years2021-09-29 | $ 87.29 | -14.14% |
10 Years2016-09-29 | $ 51.39 | 45.84% |
20 Years2006-09-28 | $ 20.34 | 268.40% |
30 Years1996-09-27 | $ 7.10 | 10x |
All Time1999-03-08 | $ 3.55 | 21x |
| Period | Last Price2026-09-29 | 1 Year2025-09-29 | 5 Years2021-09-29 | 10 Years2016-09-29 | 20 Years2006-09-28 | 30 Years1996-09-27 | All Time1999-03-08 |
|---|---|---|---|---|---|---|---|
| Price | $ 74.95 | $ 61.54 | $ 87.29 | $ 51.39 | $ 20.34 | $ 7.10 | $ 3.55 |
| Return | — | 21.80% | -14.14% | 45.84% | 268.40% | 10x | 21x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 36M | $ 10M | $ 87M |
| 2025 | $ 38M | $ 11M | $ 85M |
| 2024 | $ 40M | $ 13M | $ 82M |
| 2023 | $ 50M | $ 16M | $ 92M |
| 2022 | $ 52M | $ 16M | $ 75M |
| 2021 | $ 49M | $ 14M | $ 60M |
| 2020 | $ 42M | $ 10M | $ 51M |
| 2019 | $ 46M | $ 14M | $ 42M |
| 2018 | $ 41M | $ 18M | $ 51M |
| 2017 | $ 41M | $ 8M | $ 39M |
| 2016 | $ 39M | $ 12M | $ 26M |
| 2015 | $ 40M | $ 11M | $ 23M |
| 2014 | $ 41M | $ 11M | $ 19M |
| 2013 | $ 40M | $ 11M | $ 14M |
| 2012 | $ 41M | $ 10M | $ 8M |
| 2011 | $ 37M | $ 7M | $ 6M |
| 2010 | $ 25M | $ 6M | $ 18M |
| 2009 | $ 25M | $ 6M | $ 19M |
| 2008 | $ 27M | $ 7M | $ 16M |
| 2007 | $ 28M | $ 7M | $ 22M |
| 2006 | $ 28M | $ 8M | $ 21M |
| 2005 | $ 27M | $ 7M | $ 17M |
| 2004 | $ 26M | $ 10M | $ 16M |
| 2003 | $ 27M | $ 20M | $ 1M |
| 2002 | $ 27M | $ 7M | $ 285K |
| 2001 | $ 26M | $ 5M | $ 370K |
| 2000 | $ 27M | $ 5M | $ 414K |
| IPO1999 | $ 29M | $ 5M | $ 647K |
Utah Medical Products Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 42M to $ 38M and net income grew from $ 10M to $ 11M. Revenue increased in 1 of those 5 years; net income in 2.
Across Utah Medical Products Inc's full reported history, from 1999 to 2025, revenue grew from $ 29M to $ 38M and net income grew from $ 5M to $ 11M. Revenue increased in 41% of the years measured; net income in 48%.
Utah Medical Products Inc currently holds a 20-year HDB Score of 4.0 out of 10. How the HDB Score is calculated.
Membership
Continue UTMD’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,814 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
